Sunday, October 19, 2025 from 4:00 p.m. to 5:30 p.m. CDT at Greenway ABCDE, 2nd Floor
This session is being recorded.
Learn MoreAvailable for 1.50 hours of CPE creditActivity Number: 0217-0000-25-115-L01-PActivity Type: A Knowledge-Based ActivityCardiology care is rapidly evolving. Traditionally, the process of updating cardiovascular disease guidelines has been time-consuming, sometimes spanning a decade or more. Recent efforts by organizations such as the American College of Cardiology (ACC) and the American Heart Association (AHA) have expedited this process, particularly in key areas like atrial fibrillation, chronic coronary disease, acute coronary syndromes, and peripheral artery disease. Some of the previous guidelines for these conditions have been used in clinical practice since 2013, underscoring the pressing need for up-to-date recommendations. The goal of this program is to provide attendees with a well-rounded understanding of the most important practice-changing updates in cardiology, including how they can best influence patient care, apply treatment strategies, and plan for long-term outcomes. Experts in cardiology will highlight key information from newer guidelines in a panel format followed by a speaker Q & A.
Learning Objectives1. Review the latest practice guidelines and advancements in the management of a specific cardiovascular disease state (i.e., chronic coronary disease, acute coronary syndrome, atrial fibrillation, or peripheral artery disease).
2. Discuss how the updated guidelines influence patient care, treatment strategies, and long-term outcomes in a specific cardiovascular disease state (i.e., chronic coronary disease, acute coronary syndrome, atrial fibrillation, or peripheral artery disease).
3. Summarize recently published literature in the treatment of a specific cardiovascular disease state (i.e., chronic coronary disease, acute coronary syndrome, atrial fibrillation, or peripheral artery disease).
4. Identify controversies and challenges in the implementation and application of recent cardiology guideline updates.
5. Describe the pharmacist’s role in the management of cardiovascular disease states and implications for patient care.
 | | Moderator: | Amanda G. Sowder, Pharm.D., BCCP | | Interventional Cardiology & Electrophysiology Laboratory Pharmacist
Adventhealth Orlando | | View Biography |
|
Initial Beat: Updates from the 2023 Guideline for the Management of Chronic Coronary Disease4:00 p.m. to 4:20 p.m. | | Speaker: | Kelly C. Rogers, Pharm.D., FCCP, FACC, BCCP | | Professor of Clinical Pharmacy and Translational Science
University of Tennessee College of Pharmacy
Cardiology Clinical Pharmacy Specialist
Regional One Health
Memphis, Tennessee
| | View Biography |
|
|
Second Beat: Updates from the 2023 Guideline for the Diagnosis and Management of Atrial Fibrillation4:20 p.m. to 4:40 p.m. | | Speaker: | Kazuhiko Kido, Pharm.D., FCCP, BCPS | | Clinical Associate Professor
West Virginia University School of Pharmacy
Clinical Pharmacy Specialist, Advanced Heart Failure/Pulmonary Hypertension | | View Biography |
|
|
Third Beat: Updates from the 2024 Guideline for the Management of Peripheral Artery Disease4:40 p.m. to 5:00 p.m. | | Speaker: | Toby C. Trujillo, Pharm.D., FCCP, FAHA, BCPS | | Professor of Clinical Pharmacy
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado | | View Biography |
|
|
Final Beat: Updates from the 2025 Guideline for the Management of Acute Coronary Syndromes5:00 p.m. to 5:20 p.m. | | Speaker: | Ashley Schenk, Pharm.D., BCCP, BCPS, AACC | | Cardiology Clinical Pharmacist / Assistant Adjunct Professor, UK HealthCare / Univ of Kentucky College of Pharmacy, Lexington, KY
| | View Biography |
|
|
Q&A with Panelists5:20 p.m. to 5:30 p.m. |